{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T03:09:47Z","timestamp":1769915387268,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100020050","name":"Japan Intractable Diseases Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s10157-023-02425-y","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T09:02:12Z","timestamp":1699088532000},"page":"217-224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Practice patterns of rituximab for primary membranous nephropathy 2021 in Japan: a web-based survey of board-certified nephrologists"],"prefix":"10.1007","volume":"28","author":[{"given":"Yoshitaka","family":"Miyaoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4127-7500","authenticated-orcid":false,"given":"Noriaki","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Sofue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Nishiwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuji","family":"Ishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,4]]},"reference":[{"key":"2425_CR1","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/j.1523-1755.2004.00518.x","volume":"65","author":"H Shiiki","year":"2004","unstructured":"Shiiki H, Saito T, Nishitani Y, Mitarai T, Yorioka N, Yoshimura A, et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int. 2004;65:1400\u20137. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00518.x.","journal-title":"Kidney Int"},{"key":"2425_CR2","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s10157-020-01864-1","volume":"24","author":"R Yamamoto","year":"2020","unstructured":"Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, et al. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan nephrotic syndrome cohort study (JNSCS). Clin Exp Nephrol. 2020;24:526\u201340.","journal-title":"Clin Exp Nephrol"},{"issue":"100","key":"2425_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"2021","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO. Clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;2021(100):S1-276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021.","journal-title":"Kidney Int"},{"key":"2425_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa1814427","volume":"381","author":"FC Fervenza","year":"2019","unstructured":"Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, et al. Rituximab or cyclosporine in the treatment of membranous nephropathy. N Engl J Med. 2019;381:36\u201346. https:\/\/doi.org\/10.1056\/NEJMoa1814427.","journal-title":"N Engl J Med"},{"key":"2425_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1681\/ASN.2016040449","volume":"28","author":"K Dahan","year":"2017","unstructured":"Dahan K, Debiec H, Plaisier E, Cachanado M, Rousseau A, Wakselman L, et al. Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up. J Am Soc Nephrol. 2017;28:348\u201358. https:\/\/doi.org\/10.1681\/ASN.2016040449.","journal-title":"J Am Soc Nephrol"},{"key":"2425_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-023-02366-6","author":"T Wada","year":"2023","unstructured":"Wada T, Shimizu S, Koizumi M, Sofue T, Nishiwaki H, Sasaki S, et al. Japanese clinical practice patterns of primary nephrotic syndrome 2021: a web-based questionnaire survey of certified nephrologists. Clin Exp Nephrol. 2023. https:\/\/doi.org\/10.1007\/s10157-023-02366-6.","journal-title":"Clin Exp Nephrol"},{"key":"2425_CR7","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s10157-021-02098-5","volume":"25","author":"T Wada","year":"2021","unstructured":"Wada T, Ishimoto T, Nakaya I, Kawaguchi T, Sofue T, Shimizu S, et al. A digest of the evidence-based clinical practice guideline for nephrotic syndrome 2020. Clin Exp Nephrol. 2021;25:1277\u201385. https:\/\/doi.org\/10.1007\/s10157-021-02098-5.","journal-title":"Clin Exp Nephrol"},{"key":"2425_CR8","volume-title":"Evidence-based clinical practice guidelines for nephrotic syndrome 2020","author":"I Narita","year":"2020","unstructured":"Narita I, Okada H, Yasuda Y, Shibagaki Y, Wada T, Akiyama S, et al. Evidence-based clinical practice guidelines for nephrotic syndrome 2020. Tokyo Igakusha; 2020."},{"key":"2425_CR9","doi-asserted-by":"publisher","first-page":"e110376","DOI":"10.1371\/journal.pone.0110376","volume":"9","author":"M Yamaguchi","year":"2014","unstructured":"Yamaguchi M, Ando M, Yamamoto R, Akiyama S, Kato S, Katsuno T, et al. Patient age and the prognosis of idiopathic membranous nephropathy. PLoS ONE. 2014;9:e110376. https:\/\/doi.org\/10.1371\/journal.pone.0110376.","journal-title":"PLoS ONE"},{"key":"2425_CR10","unstructured":"Japan Post. ZIP code data download\/explanation of ZIP code data (In Japanese). Japan Post Co. Ltd; 2023. https:\/\/www.post.japanpost.jp\/zipcode\/dl\/readme.html. Accessed 15 Jun 2023"},{"key":"2425_CR11","unstructured":"Japan Post. ZIP code data download\/explanation of individual code data for big business offices\n(In Japanese). Japan Post Co. Ltd; 2023. https:\/\/www.post.japanpost.jp\/zipcode\/dl\/jigyosyo\/readme.html"},{"key":"2425_CR12","unstructured":"Official statistics of Japan. Dataset list\/Census\/2020 key results by prefecture and municipality (In Japanese). statistics bureau, ministry of internal affairs and communications; 2022. https:\/\/www.e-stat.go.jp\/stat-search\/files?page=1&layout=datalist&toukei=00200521&tstat=000001049104&cycle=0&tclass1=000001049105&tclass2val=0. Accessed 15 Jun 2023"},{"key":"2425_CR13","first-page":"133","volume-title":"Effective use of the McNemar test. Behav ecol sociobiol","author":"MQR Pembury Smith","year":"2020","unstructured":"Pembury Smith MQR, Ruxton GD. Effective use of the McNemar test. Behav ecol sociobiol, vol. 74. Springer; 2020. p. 133."},{"key":"2425_CR14","first-page":"274","volume-title":"Analysis of matched cohort data. Stata J","author":"P Cummings","year":"2004","unstructured":"Cummings P, McKnight B. Analysis of matched cohort data. Stata J, vol. 4. SAGE Publications; 2004. p. 274\u201381."},{"key":"2425_CR15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/aje\/kwaa044","volume":"189","author":"AI Naimi","year":"2020","unstructured":"Naimi AI, Whitcomb BW. Estimating risk ratios and risk differences using regression. Am J Epidemiol. 2020;189:508\u201310. https:\/\/doi.org\/10.1093\/aje\/kwaa044.","journal-title":"Am J Epidemiol"},{"key":"2425_CR16","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/aje\/kwf215","volume":"157","author":"JA Hanley","year":"2003","unstructured":"Hanley JA, Negassa A, Edwardes MDD, Forrester JE. Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol. 2003;157:364\u201375. https:\/\/doi.org\/10.1093\/aje\/kwf215.","journal-title":"Am J Epidemiol"},{"key":"2425_CR17","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s10157-021-02035-6","volume":"25","author":"M Kobayashi","year":"2021","unstructured":"Kobayashi M, Kageyama Y, Ando T, Sakamoto J, Kimura S. All-case Japanese post-marketing surveillance of the real-world safety and efficacy of rituximab treatment in patients with refractory nephrotic syndrome. Clin Exp Nephrol. 2021;25:854\u201364. https:\/\/doi.org\/10.1007\/s10157-021-02035-6.","journal-title":"Clin Exp Nephrol"},{"key":"2425_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13012-017-0555-2","volume":"12","author":"DM Gupta","year":"2017","unstructured":"Gupta DM, Boland RJ Jr, Aron DC. The physician\u2019s experience of changing clinical practice: a struggle to unlearn. Implement Sci. 2017;12:28. https:\/\/doi.org\/10.1186\/s13012-017-0555-2.","journal-title":"Implement Sci"},{"key":"2425_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/jjco\/hyac034","volume":"52","author":"J Eba","year":"2022","unstructured":"Eba J, Nakamura K. Overview of the ethical guidelines for medical and biological research involving human subjects in Japan. Jpn J Clin Oncol. 2022;52:539\u201344. https:\/\/doi.org\/10.1093\/jjco\/hyac034.","journal-title":"Jpn J Clin Oncol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-023-02425-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-023-02425-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-023-02425-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T10:03:11Z","timestamp":1708768991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-023-02425-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,4]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["2425"],"URL":"https:\/\/doi.org\/10.1007\/s10157-023-02425-y","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,4]]},"assertion":[{"value":"26 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Honoraria: Noriaki Kurita, GlaxoSmithKline K.K.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was an anonymous survey of healthcare professionals to describe the practice of primary nephrotic syndrome treatment and was considered outside the scope of the ethical review according to the Ethical Guidelines for Medical and Biological Research Involving Human Subjects. [] The possibility of academic publication of the survey results was described at the beginning of the questionnaire, and only those who provided consent to complete the survey were included.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}